Flu Vaccinations 2021 - Search News

FDA to review Moderna's mRNA flu vaccine

Dermatology Advisor · 1d

FDA Declines to Review Moderna’s mRNA Flu Vaccine Application

The FDA issued a refuse-to-file letter for Moderna’s mRNA-based flu vaccine amid a shift toward stricter scrutiny of mRNA technology.

Continue reading

· 1d · on MSN

Moderna shares rally 6% after FDA reverses decision not to review flu vaccine

Moderna Spikes After FDA’s About-Face on mRNA Flu Vaccine

Moderna Says the FDA Will Consider Its New Flu Shot After Resolving a Public Dispute

The Food and Drug Administration will consider whether to approve Moderna’s new flu vaccine after all, resolving a dispute that had blocked the company’s application for the first-of-its-kind shot.

Continue reading

FDA reverses course, will review Moderna's mRNA flu vaccine

FDA Reverses Course and Will Now Review Moderna’s Flu Shot

F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine

Dr. Stephen Hoge, Moderna’s president, said on Fox Business on Wednesday that Moderna and its peers needed clear and consistent rules from regulators.

Continue reading

Moderna Announces the U.S. Food and Drug Administration will Initiate the Review of Its Investigational Seasonal Influenza Vaccine Submission

FDA reverses surprise rejection of Moderna’s mRNA flu vaccine